Selling and Marketing Expense of Coeptis Therapeutics Holdings, Inc. from 31 Dec 2021 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Coeptis Therapeutics Holdings, Inc. quarterly and annual Selling and Marketing Expense in USD history and change rate from 31 Dec 2021 to 31 Mar 2025.
  • Coeptis Therapeutics Holdings, Inc. Selling and Marketing Expense for the quarter ending 31 Mar 2025 was $106,500.
  • Coeptis Therapeutics Holdings, Inc. annual Selling and Marketing Expense for 2023 was $12,710, a 53% increase from 2022.
  • Coeptis Therapeutics Holdings, Inc. annual Selling and Marketing Expense for 2022 was $8,331, a 186% increase from 2021.
Source SEC data
View on sec.gov
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Change (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Change (%)

Coeptis Therapeutics Holdings, Inc. Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $106,500 +$106,500 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q3 2024 $0 -$12,412 -100% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $5,000 +$4,700 +1567% 01 Apr 2024 30 Jun 2024 10-Q 16 Aug 2024 2024 Q2
Q1 2024 $0 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q3 2023 $12,412 +$9,553 +334% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $300 -$3,752 -93% 01 Apr 2023 30 Jun 2023 10-Q 16 Aug 2024 2024 Q2
Q3 2022 $2,859 01 Jul 2022 30 Sep 2022 10-Q/A 16 Aug 2024 2023 Q3
Q2 2022 $4,052 01 Apr 2022 30 Jun 2022 10-Q/A 25 Mar 2024 2023 Q2

Coeptis Therapeutics Holdings, Inc. Annual Selling and Marketing Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $12,710 +$4,379 +53% 01 Jan 2023 31 Dec 2023 10-K/A 16 Aug 2024 2023 FY
2022 $8,331 +$5,413 +186% 01 Jan 2022 31 Dec 2022 10-K/A 16 Aug 2024 2023 FY
2021 $2,918 01 Jan 2021 31 Dec 2021 10-K/A 25 Mar 2024 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.